Laws, Regulations & Activism
WHAT’S NEW
Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals....
In part one of a series of articles on ibogaine clinics, researcher Leonard Pickard looks at the history and treatment protocols o...
Underscoring an anecdotal observation common among cannabis consumers, a group of researchers in Canada have released a new study ...
POPULAR ARTICLES
MindMed: Can the Former Darlings of the Psychedelic Biotech Sector Avoid Collapse?
After MindMed\'s up-listing, the company has been facing a lot of instability and turbulence in the past few months and years. It ...
Read More
Surge in microdosing interest linked to loosened drug regulations, study finds
Researchers observed a 1250% increase in microdosing-related Google searches from 2015 to 2023, coinciding with the loosening of c...
Read More
Psilocybin might be effective for treatment-resistant depression even with ongoing SSRI use, study suggests
In a phase II clinical trial, a single dose of psilocybin, combined with SSRI treatment and supportive therapy, showed promising s...
Read More
Proposed kratom ban would harm the public, damage FDA’s credibility
Prohibiting substances like kratom without good evidence for doing so can be just as harmful as approving them without it....
Read More
Doctors To Begin Trial For Psilocybin Therapy To Treat Cancer-Related Anxiety, Depression
“Psychedelics, specifically psilocybin, have shown promise in treating various psychological symptoms including anxiety, dep...
Read More
Could This Psychedelic Root Solve The Opioid Crisis?
The Iboga plant has been used for tribal rituals in Central Africa for millennia. While the highly toxic root causes days-long hal...
Read More